Delluc A[au] - Search Results

Year	Number of Results
1986	1
2004	1
2005	1
2006	3
2007	2
2008	5
2009	4
2010	4
2011	7
2012	12
2013	6
2014	11
2015	12
2016	10
2017	13
2018	12
2019	11
2020	8
2021	15
2022	5

1

Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis.

Wang TF, Carrier M, Fournier K, Siegal DM, Le Gal G, Delluc A. Wang TF, et al. Among authors: delluc a. Thromb Haemost. 2021 Aug 16. doi: 10.1055/a-1588-9155. Online ahead of print. Thromb Haemost. 2021. PMID: 34399433

2

Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review.

Makedonov I, Kahn SR, Abdulrehman J, Schulman S, Delluc A, Gross P, Galanaud JP. Makedonov I, et al. Among authors: delluc a. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263. Online ahead of print. Thromb Haemost. 2021. PMID: 34852380 Free article.

3

[What is the management of sub-segmental pulmonary embolism?].

Benhamou Y, Delluc A, Sanchez O; groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. Benhamou Y, et al. Among authors: delluc a. Rev Mal Respir. 2021 Apr;38 Suppl 1:e161-e163. doi: 10.1016/j.rmr.2019.05.013. Epub 2019 Nov 6. Rev Mal Respir. 2021. PMID: 31703828 French. No abstract available.

4

Arterial and venous thrombosis: What's the link? A narrative review.

Delluc A, Lacut K, Rodger MA. Delluc A, et al. Thromb Res. 2020 Jul;191:97-102. doi: 10.1016/j.thromres.2020.04.035. Epub 2020 Apr 27. Thromb Res. 2020. PMID: 32416310 Review.

5

[Which aetiological investigations to undertake during the progress of PE/DVT?].

Benhamou Y, Delluc A, Mauge L, Fischer AM, Sanchez O; pour le groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. Benhamou Y, et al. Among authors: delluc a. Rev Mal Respir. 2021 Apr;38 Suppl 1:e90-e98. doi: 10.1016/j.rmr.2019.05.008. Epub 2021 Mar 18. Rev Mal Respir. 2021. PMID: 33744073 French. No abstract available.

6

Thromboprophylaxis in patients with multiple myeloma.

Wang TF, Delluc A. Wang TF, et al. Among authors: delluc a. Br J Haematol. 2020 Aug;190(4):493-494. doi: 10.1111/bjh.16731. Epub 2020 May 12. Br J Haematol. 2020. PMID: 32395827 No abstract available.

7

Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.

Rézig S, Mao RL, Couturaud F, Lacut K, Delluc A. Rézig S, et al. Among authors: delluc a. Thromb Haemost. 2019 Mar;119(3):490-495. doi: 10.1055/s-0039-1677745. Epub 2019 Jan 27. Thromb Haemost. 2019. PMID: 30685873

8

[What are the special features of treatment in the anti-phospho-lipid syndrome?].

Benhamou Y, Delluc A, Fischer AM, Sanchez O; groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. Benhamou Y, et al. Among authors: delluc a. Rev Mal Respir. 2021 Apr;38 Suppl 1:e153-e156. doi: 10.1016/j.rmr.2019.05.017. Epub 2019 Oct 11. Rev Mal Respir. 2021. PMID: 31611023 French. No abstract available.

9

How to treat incidental pulmonary embolism in cancer patients? Recent advances.

Delluc A, Wang TF. Delluc A, et al. Kardiol Pol. 2021;79(12):1305-1310. doi: 10.33963/KP.a2021.0164. Epub 2021 Nov 30. Kardiol Pol. 2021. PMID: 34845714 Free article. Review.

10

Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Cacoub P, et al. Among authors: delluc a. Ann Rheum Dis. 2008 Mar;67(3):283-7. doi: 10.1136/ard.2006.065565. Epub 2007 Jul 20. Ann Rheum Dis. 2008. PMID: 17644544 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results